CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells is a research paper published in iScience (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA211014
National Cancer Institute
Grant: T32CA090223
National Cancer Institute
Grant: P30 CA016058
NCI NIH HHS
Grant: R01 CA247941
NIAID NIH HHS
Grant: R01 AI114581
NIAID NIH HHS
Grant: R01 AI175004
NCI NIH HHS
Grant: U01 CA232488
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5R01CA211014-02
CD200R signaling in tumor growth, immunity and immunotherapy
National Institutes of Health
Grant: 5T32CA090223-03
Tumor Immunology
NIH
FWCI
0.92
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals